BIOMAT Database Logo BIOMAT Database Logo

[Immunogenic and reactogenic properties of inactivated influenza vaccine purified and concentrated by gradient centrifugation]. 1982

E V Malikova, and L S Safonova, and L P Zueva, and G M Znakova

UI MeSH Term Description Entries
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D002499 Centrifugation, Density Gradient Separation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Centrifugations, Density Gradient,Density Gradient Centrifugation,Density Gradient Centrifugations,Gradient Centrifugation, Density,Gradient Centrifugations, Density
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated

Related Publications

E V Malikova, and L S Safonova, and L P Zueva, and G M Znakova
Clinico-immunologic and allergologic studies with the inactivated influenza virus vaccine purified and concentrated by gradient centrifugation.
November 1988, Acta virologica,
E V Malikova, and L S Safonova, and L P Zueva, and G M Znakova
[Immunogenic and reactogenic properties of commercial series of inactivated chromatographic influenza vaccine].
January 1979, Trudy Instituta imeni Pastera,
E V Malikova, and L S Safonova, and L P Zueva, and G M Znakova
[Evaluation data from experimental series on a killed influenza vaccine purified and concentrated by differential and density gradient centrifugation. II. The results of a study of the reactogenic properties of the vaccine].
January 1976, Trudy Instituta imeni Pastera,
E V Malikova, and L S Safonova, and L P Zueva, and G M Znakova
Immunogenicity of Concentrated and Purified Inactivated Avian Influenza Vaccine Formulation.
December 2018, Archives of Razi Institute,
E V Malikova, and L S Safonova, and L P Zueva, and G M Znakova
Antigenicity of inactivated swine influenza virus concentrated by centrifugation.
January 1976, Research communications in chemical pathology and pharmacology,
E V Malikova, and L S Safonova, and L P Zueva, and G M Znakova
[Characteristics of the reactogenic and immunogenic properties of killed influence vaccine purified and concentrated by the method of adsorbed chromatography on silicate sorbents].
September 1976, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
E V Malikova, and L S Safonova, and L P Zueva, and G M Znakova
THE PREPARATION AND PROPERTIES OF INFLUENZA VIRUS VACCINES CONCENTRATED AND PURIFIED BY DIFFERENTIAL CENTRIFUGATION.
February 1945, The Journal of experimental medicine,
E V Malikova, and L S Safonova, and L P Zueva, and G M Znakova
The effectiveness of inactivated, purified and concentrated experimental rabies vaccine for veterinary use: immunogenic activity.
February 1997, Veterinarni medicina,
E V Malikova, and L S Safonova, and L P Zueva, and G M Znakova
[Evaluation data from experimental series on a killed influenza vaccine purified and concentrated by differential and density gradient centrifugation. I. Laboratory evaluation data].
January 1976, Trudy Instituta imeni Pastera,
E V Malikova, and L S Safonova, and L P Zueva, and G M Znakova
Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy.
January 1969, Bulletin of the World Health Organization,
Copied contents to your clipboard!